MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Encephalomyelopathy Due to Cerebrotendinous Xanthomatosis

ACO. Oliveira, LFV. Vasconcellos, BXC. Cordeiro, LLN. Najar (Rio de Janeiro, Brazil)

Meeting: 2019 International Congress

Abstract Number: 534

Keywords: Ataxia: Genetics, Dementia, Functional magnetic resonance imaging(fMRI)

Session Information

Date: Monday, September 23, 2019

Session Title: Rare Genetic and Metabolic Diseases

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To present a case in which the MRI of a patient with cerebrotendinous xanthomatosis (CTX)  revelaled impairment of whole neuroaxis.

Background: CTX is a rare autosomal recessive leukodystrophy caused by mutations in the CYP27A1 gene, which encodes sterol 27-hidroxylase. The deficiency of this enzyme causes the accumulation of cholesterol and cholestanol, resulting in xanthomas in tendons, CNS, skin and other organs. Clinical and imaging aspects of CTX is variable.

Method: A 56-year-old caucasian woman presented with progressive ataxia (over 40 years), behavioral and cognitive impairment and dysarthria.She reported learning difficulties since childhood, episodic diarrhea and juvenile cataracts. Her cognitive and physical condition gradually deteriorated over years but maintaining independence for some activities of daily living. Her paternal grandfather and aunt had ataxia and dementia without diagnostic confirmation. There was no parent consanguinity. Physical examination revealed gait ataxia, dysmetria in 4 limbs, dysarthria, and brisk tendon reflex with bilateral Babinski sing. There was also bilateral pes cavus as well achilles and patellar tendons xanthomas.(Fig.1). Brain and spinal cord MRI showed diffuse symmetrical white matter hyperintensities on axial T2/FLAIR. (Fig. 2,3 e 4); Serum cholestanol : 1,81 (Reference:0,248).

Results: The main clinical manifestations are cataracts, premature atherosclerosis, tendon xanthomas and neurological impairment; The neuroimaging revealed brain, cerebellar and spinal cord white matter hyperintensities involving the brain, cerebellum and spinal cord (encephalomyelopathy);

Conclusion: CTX should be considered in the differential diagnosis of progressive encephalomyelopathies; Early diagnosis is crucial as it is a treatable inherited leukodystrophy.

Fig 1

Fig 2

Fig 3

To cite this abstract in AMA style:

ACO. Oliveira, LFV. Vasconcellos, BXC. Cordeiro, LLN. Najar. Encephalomyelopathy Due to Cerebrotendinous Xanthomatosis [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/encephalomyelopathy-due-to-cerebrotendinous-xanthomatosis/. Accessed May 17, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/encephalomyelopathy-due-to-cerebrotendinous-xanthomatosis/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley